Dan Swerdlow is a physician scientist with over 15 years of experience in drug discovery, translational medicine, and early clinical development. They have led multi-professional teams across tech, biotech, pharma, academia, and clinical medicine, focusing on the integration of human genomic evidence in therapeutic development. Dan's career journey includes significant roles at institutions such as the University College London, Genomics plc, and Silence Therapeutics plc, where they worked on clinical trials, target identification, and precision medicine initiatives. Currently, Dan serves as a Senior Director at GSK, leading translational and experimental medicine for RNA therapeutics. Dan holds an MD PhD in genetic epidemiology, with a strong foundation from University College London.
This person is not in the org chart
This person is not in any teams
This person is not in any offices